Squarepoint Ops LLC purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 303,567 shares of the health services provider's stock, valued at approximately $22,661,000. Squarepoint Ops LLC owned about 0.53% of Maximus as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank acquired a new position in shares of Maximus in the 4th quarter valued at $71,443,000. SG Capital Management LLC bought a new stake in shares of Maximus in the fourth quarter worth about $30,285,000. Federated Hermes Inc. increased its stake in Maximus by 74.8% during the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock worth $65,912,000 after purchasing an additional 377,705 shares in the last quarter. AQR Capital Management LLC raised its holdings in Maximus by 189.1% during the 4th quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock worth $31,599,000 after buying an additional 276,859 shares during the period. Finally, Marshall Wace LLP lifted its stake in Maximus by 1,319.1% in the fourth quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider's stock valued at $16,742,000 after buying an additional 208,463 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Maximus Stock Down 1.8%
Shares of NYSE:MMS traded down $1.33 during trading on Monday, hitting $72.36. 456,402 shares of the company were exchanged, compared to its average volume of 562,495. The stock has a market cap of $4.08 billion, a price-to-earnings ratio of 15.56 and a beta of 0.61. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The firm has a fifty day moving average price of $69.37 and a two-hundred day moving average price of $72.05.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.57 EPS. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.66%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is currently 23.86%.
Insider Buying and Selling
In other news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Get Our Latest Stock Report on MMS
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.